@article{PietschKubowiczThuenemannetal.2003, author = {Pietsch, Ullrich and Kubowicz, Stephan and Th{\"u}nemann, Andreas F. and Geue, Thomas and Watson, M. D. and Tchebotareva, N. and M{\"u}llen, K.}, title = {X-ray reflectivity study of an amphiphilic hex-peri-hexabenzocoronene at a structured silicon wafer surface}, year = {2003}, language = {en} } @article{FormerWagnerRichertetal.1999, author = {Former, C. and Wagner, H. and Richert, R. and Neher, Dieter and M{\"u}llen, K.}, title = {Orientation and dynamics of chainlike dipole arrays: Donor-acceptor-substituted oligophenylenevinylenes in a polymer matrix}, year = {1999}, language = {en} } @article{QuZhangGrimsdaleetal.2004, author = {Qu, J. Q. and Zhang, J. Y. and Grimsdale, A. C. and Mullen, K. and Jaiser, Frank and Yang, X. H. and Neher, Dieter}, title = {Dendronized perylene diimide emitters : Synthesis, luminescence, and electron and energy transfer studies}, issn = {0024-9297}, year = {2004}, abstract = {Aggregation of chromophores in the solid state commonly causes undesirable red shifts in the emission spectra and/or emission quenching. To overcome this problem, we have prepared soluble perylenetetracarboxidiimide dyes in which the chromophores are effectively shielded by polyphenylene dendrimers attached in the bay positions. Models show that attachment of the shielding units in the bay position should provide more efficient shielding than attaching them via the imide moieties. The dendrimers possess excellent film-forming properties due to alkyl substituents on their peripheries. The lack of a red shift in emission upon going from solution to the solid state indicates the dendrons suppress interaction of the emissive cores, leading to pure red-orange emission. Single-layer LEDs produce red-orange emission with relatively low efficiency especially for the higher generation dendrons, which is attributed to poor charge conduction. LEDs using blends of the dendrimers and the undendronized dye as a model compound in PVK have been investigated, and a model to extract relative charge injection rates through the dendritic scaffold from the spectral contributions in the EL spectra is developed}, language = {en} } @article{SigelSwartzGoldenetal.2020, author = {Sigel, Keith Magnus and Swartz, Talia H. and Golden, Eddye and Paranjpe, Ishan and Somani, Sulaiman and Richter, Felix and De Freitas, Jessica K. and Miotto, Riccardo and Zhao, Shan and Polak, Paz and Mutetwa, Tinaye and Factor, Stephanie and Mehandru, Saurabh and Mullen, Michael and Cossarini, Francesca and B{\"o}ttinger, Erwin and Fayad, Zahi and Merad, Miriam and Gnjatic, Sacha and Aberg, Judith and Charney, Alexander and Nadkarni, Girish and Glicksberg, Benjamin S.}, title = {Coronavirus 2019 and people living with human immunodeficiency virus}, series = {Clinical infectious diseases : electronic edition}, volume = {71}, journal = {Clinical infectious diseases : electronic edition}, number = {11}, publisher = {Oxford Univ. Press}, address = {Cary, NC}, issn = {1058-4838}, doi = {10.1093/cid/ciaa880}, pages = {2933 -- 2938}, year = {2020}, abstract = {Background: There are limited data regarding the clinical impact of coronavirus disease 2019 (COVID-19) on people living with human immunodeficiency virus (PLWH). In this study, we compared outcomes for PLWH with COVID-19 to a matched comparison group. Methods: We identified 88 PLWH hospitalized with laboratory-confirmed COVID-19 in our hospital system in New York City between 12 March and 23 April 2020. We collected data on baseline clinical characteristics, laboratory values, HIV status, treatment, and outcomes from this group and matched comparators (1 PLWH to up to 5 patients by age, sex, race/ethnicity, and calendar week of infection). We compared clinical characteristics and outcomes (death, mechanical ventilation, hospital discharge) for these groups, as well as cumulative incidence of death by HIV status. Results: Patients did not differ significantly by HIV status by age, sex, or race/ethnicity due to the matching algorithm. PLWH hospitalized with COVID-19 had high proportions of HIV virologic control on antiretroviral therapy. PLWH had greater proportions of smoking (P < .001) and comorbid illness than uninfected comparators. There was no difference in COVID-19 severity on admission by HIV status (P = .15). Poor outcomes for hospitalized PLWH were frequent but similar to proportions in comparators; 18\% required mechanical ventilation and 21\% died during follow-up (compared with 23\% and 20\%, respectively). There was similar cumulative incidence of death over time by HIV status (P = .94). Conclusions: We found no differences in adverse outcomes associated with HIV infection for hospitalized COVID-19 patients compared with a demographically similar patient group.}, language = {en} }